TMRW Life Sciences
Private Company
Total funding raised: $102M
Overview
TMRW Life Sciences is a private, commercial-stage company offering a comprehensive digital platform for automated fertility specimen storage. Its core technology integrates RFID-enabled cryo-storage hardware (robots, vaults, biorepositories) with a HIPAA-compliant cloud software suite (ivfOS) to provide a complete digital chain of custody and real-time monitoring. The company targets in-vitro fertilization (IVF) clinics seeking to reduce operational risk, optimize lab space, and scale their storage capacity while offering patients greater transparency and security for their stored genetic material. TMRW's solutions are deployed with leading fertility clinic networks across the United States.
Technology Platform
Integrated digital platform combining RFID-enabled cryogenic storage hardware (CryoRobot, Vault), cloud-based specimen management software (ivfOS), and 24/7 remote monitoring (Overwatch®) for automated, traceable storage of eggs, embryos, and sperm.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
TMRW operates in a niche with limited direct competitors offering a fully integrated, automated, and FDA-cleared platform. Traditional competition consists of manual storage in dewars from suppliers like Thermo Fisher, and basic barcode-based inventory systems. The primary competitive threat is from new entrants developing similar automated solutions, but TMRW's regulatory clearances and early clinic partnerships create a significant barrier to entry.